Dr. Agarwal’s Health Care Limited has delivered a stellar performance for FY2026, with total income rising 20.9% year-on-year to INR 2,125 crores. The company achieved a significant milestone by crossing INR 2,000 crores in revenue from operations. Profit after tax saw a massive 52.4% increase to INR 168 crores. The company expanded its network to 288 facilities across 10 countries, supported by effective cost-management strategies and operational growth.
Financial Performance Highlights
The company reported robust growth for the fiscal year ended March 31, 2026. Revenue from operations reached INR 2,080 crores, marking a 21.6% increase compared to the previous year. EBITDA grew by 22.2% to INR 614 crores, reflecting strong operational efficiency and a margin of 28.9%. The significant 52.4% growth in Profit after Tax to INR 168 crores highlights the company’s ability to drive profitability amidst rapid scaling.
Expansion and Operational Growth
During the fiscal year, the company commissioned 57 new facilities, averaging one new center every single week. This expansion entered 26 new cities, bringing the total network to 288 facilities. Of these new additions, 30 were surgical centers, which significantly bolstered the company’s clinical capacity. A key highlight of the year was the successful entry into Delhi NCR with six operational facilities established in under twelve months.
Strategic Reallocation of IPO Proceeds
The company successfully completed its Initial Public Offering with lower-than-anticipated costs due to effective competitive negotiations. Consequently, the Board of Directors approved the reallocation of the unspent ‘Issue Related Expenses’ portion toward ‘General Corporate Purposes and Unidentified Inorganic Acquisitions’. This strategic move creates a robust liquidity buffer, positioning the company to scale existing operations and address potential future contingencies with greater flexibility.
Source: BSE
